UCB SA (VIE:UCB)
183.45
-7.80 (-4.08%)
At close: Aug 1, 2025, 5:30 PM CET
SpringWorks Therapeutics Revenue
UCB SA had revenue of 3.36B EUR in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 6.85B, up 25.56% year-over-year. In the year 2024, UCB SA had annual revenue of 6.15B with 18.72% growth.
Revenue (ttm)
6.85B
Revenue Growth
+25.56%
P/S Ratio
5.13
Revenue / Employee
743.14K
Employees
9,378
Market Cap
35.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.15B | 970.00M | 18.72% |
Dec 31, 2023 | 5.18B | -265.00M | -4.87% |
Dec 31, 2022 | 5.45B | -330.00M | -5.71% |
Dec 31, 2021 | 5.78B | 430.00M | 8.04% |
Dec 31, 2020 | 5.35B | 434.00M | 8.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Erste Group Bank AG | 10.88B |
VERBUND AG | 8.39B |
OMV Aktiengesellschaft | 33.19B |
Strabag SE | 17.43B |
BAWAG Group AG | 1.77B |
Raiffeisen Bank International AG | 8.75B |
Telekom Austria AG | 5.42B |
Andritz AG | 7.97B |